1. Home
  2. EDIT vs DIN Comparison

EDIT vs DIN Comparison

Compare EDIT & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.95

Market Cap

432.8M

Sector

Health Care

ML Signal

HOLD

DIN

Dine Brands Global Inc.

HOLD

Current Price

$35.84

Market Cap

399.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDIT
DIN
Founded
2013
1958
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
432.8M
399.8M
IPO Year
2016
1994

Fundamental Metrics

Financial Performance
Metric
EDIT
DIN
Price
$2.95
$35.84
Analyst Decision
Strong Buy
Hold
Analyst Count
5
7
Target Price
$5.30
$29.00
AVG Volume (30 Days)
1.5M
239.7K
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
2.78%
EPS Growth
37.50
N/A
EPS
N/A
0.92
Revenue
$31,937,000.00
$879,300,000.00
Revenue This Year
N/A
$3.61
Revenue Next Year
N/A
$0.64
P/E Ratio
N/A
$38.80
Revenue Growth
132.64
8.25
52 Week Low
$1.66
$20.55
52 Week High
$4.54
$39.68

Technical Indicators

Market Signals
Indicator
EDIT
DIN
Relative Strength Index (RSI) 54.87 55.07
Support Level $2.40 $33.50
Resistance Level $3.27 $36.38
Average True Range (ATR) 0.15 1.42
MACD 0.03 -0.06
Stochastic Oscillator 73.39 79.76

Price Performance

Historical Comparison
EDIT
DIN

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.

About DIN Dine Brands Global Inc.

Dine Brands Global Inc owns and franchises thousands of restaurants under the International House of Pancakes (IHOP), Applebee's Neighborhood Grill + Bar (Applebee's), and the Fuzzy's Taco Shop (Fuzzy's) names. The company conducts its business through three reportable segments: Franchise, Company-owned restaurants, and Rental. The majority of its revenue is generated from the Franchise segment, which consists of IHOP, Applebee's, and Fuzzy's franchise operations and generates revenue mainly from royalties and advertising fees from several IHOP, Applebee's, and Fuzzy's franchised restaurants, in addition to revenues from the sale of proprietary IHOP and Fuzzy's products to its franchisees. Geographically, the majority of the company's revenues is generated from its domestic market.

Share on Social Networks: